Press release
Top Market Shifts Transforming the Shingles Vaccine Market Landscape: Key Insights
Shingles Vaccine
What Is the Expected CAGR for the Shingles Vaccine Market Through 2025?
The market for the shingles vaccine has experienced swift growth in past years. Projections show that it will increase from $4.82 billion in 2024 to $5.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.0%. This surge during the historic period is a result of factors such as a growing older population, heightened awareness about the advantages of vaccines, expanding healthcare infrastructure and immunization schemes, increasing occurrence of conditions that compromise the immune system, and rising uptake of more recent, high-efficacy vaccines.
What's the Projected Size of the Global Shingles Vaccine Market by 2029?
Expectations are high for the shingles vaccine market size to experience significant expansion in the coming years, with a projected rise to $9.58 billion in 2029 and a 14.6% compound annual growth rate (CAGR). Various factors are contributing to this anticipated growth during the forecast period; including the increase in government reimbursement and appealing pricing strategies, a rise in the rate of physician referrals, the heightened focus on adult immunization in public health agendas, considerable investment in product diversification and R&D, and enhancements in the global supply chain and cold-chain capacity. Looking forward, the forecast period is expected to see the evolution of recombinant vaccine technology, progression in adjuvant systems, the inclusion of shingles vaccinations in adult immunization timetables, the integration of digital health technology for tracking vaccines, and advancements in vaccine formulations.
View the full report here:
https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report
Top Growth Drivers in the Shingles Vaccine Industry: What's Accelerating the Market?
The growth trajectory of the shingles vaccine market is projected to be positively influenced by the rising number of vaccination schemes. The term 'vaccination schemes' primarily indicates publicly organized health interventions that involve systematic vaccine administration to communities for inhibiting the transmission of contagious diseases. The proliferation of these schemes is resulting from growing awareness regarding the benefits of preventive healthcare, subsequently inspiring more individuals to opt for vaccination to preempt illnesses. By fostering public awareness and accessibility, vaccination programs help enlarge the user base of the shingles vaccine, rendering them particularly beneficial for seniors and vulnerable groups. These programs aid in reducing shingles and associated complications incidence by advocating for timely and extensive immunization, thereby improving overall public health. For example, as reported by the World Health Organization in July 2025, a Switzerland-based Intergovernmental entity, the reach for the primary dose of the human papillomavirus (HPV) vaccine in females witnessed a surge from 27% in 2023 to 31% in 2024. Thus, the escalating number of vaccination schemes is a key growth driver for the shingles vaccine market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp
Which Emerging Trends Are Transforming the Shingles Vaccine Market in 2025?
Leading corporations in the shingles vaccine market are concentrating on the creation of innovative vaccine compounds, such as recombinant adjuvanted vaccines, to strengthen immune response and offer continuous protection from shingles. By combining lab-created viral proteins with adjuvants, recombinant adjuvanted vaccines can enhance the body's immune resilience for greater and longer-lasting protection. For example, GlaxoSmithKline Pharmaceuticals Ltd., an pharmaceutical firm based in India, introduced a shingles vaccine called Shingrix in April 2023. Aimed at adults aged 50 and over, Shingrix is a non-live, recombinant adjuvanted subunit vaccine given in two intramuscular doses to prevent shingles (herpes zoster) and its subsequent issue, post-herpetic neuralgia. This vaccine, with an effectiveness rate of over 90%, offers strong and long-lasting immunity for at least 10 years, benefiting even older adults and those with compromised immune systems.
What Are the Main Segments in the Shingles Vaccine Market?
The shingles vaccine market covered in this report is segmented
1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine
2) By Product: Shingrix, Zostavax, Skyzoster
3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above
4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
5) By End User: Hospitals, Clinics, Pharmacies
Subsegments:
1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C
2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine
3) By Subunit Vaccine: Protein Subunit Vaccine, Polysaccharide Subunit Vaccine, Conjugate Subunit Vaccine
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27413&type=smp
Which Top Companies are Driving Growth in the Shingles Vaccine Market?
Major companies operating in the shingles vaccine market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., GSK plc, Daiichi Sankyo Company Limited, Moderna Inc., Novavax Inc., Biological E. Limited., Serum Institute of India Pvt. Ltd., Dynavax Technologies Corporation, SK Bioscience Co. Ltd., CanSino Biologics Inc., Vaxart Inc., EuBiologics Co. Ltd., BCHT Biotech Co. Ltd., Green Cross Corp, Jiangsu Recbio Technology Co. Ltd., Curevo Inc., Inovio Pharmaceuticals Inc., POP Biotechnologies Inc.
Which Regions Will Dominate the Shingles Vaccine Market Through 2029?
North America was the largest region in the shingles vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27413
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Market Shifts Transforming the Shingles Vaccine Market Landscape: Key Insights here
News-ID: 4171516 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
